sulofenur has been researched along with Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avery, L; Bowman, LC; Luo, X; Marina, N; Meyer, WH; Pappo, A; Pratt, CB | 1 |
| Brown, TD; Burris, HA; Cagnola, J; Craig, JB; Grindey, GB; Hamilton, JM; Havlin, K; Kuhn, JG; O'Rourke, TJ; Satterlee, WG | 1 |
| Andersen, E; Andersen, H; Hansen, HH; Krarup-Hansen, A; Pedersen, H | 1 |
| Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR | 1 |
| Diasio, RB; Stagg, MP | 1 |
| Hamada, K; Inoue, K; Mukaiyama, T; Ogawa, M; Shibata, H; Wang, Y | 1 |
| Grindey, G; Hainsworth, JD; Hamilton, M; Hande, KR; Jackson, L; Kuttesch, J; Satterlee, W | 1 |
| Greco, FA; Grindey, G; Hainsworth, JD; Hande, KR; Jackson, LE; Johnson, DH; Kuttesch, J; Satterlee, WG | 1 |
| Alberts, DS; Hamilton, M; Holdsworth, MT; Ketcham, MA; McCloskey, TM; Peng, YM; Plezia, PM; Roe, DJ; Satterlee, WG; Taylor, CW | 1 |
2 review(s) available for sulofenur and Neoplasms
| Article | Year |
|---|---|
New anticancer agents.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate | 1991 |
Novel chemotherapeutic agents in early clinical development.
Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate | 1990 |
4 trial(s) available for sulofenur and Neoplasms
| Article | Year |
|---|---|
A phase I study of sulofenur in refractory pediatric malignant solid tumors.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drugs, Investigational; Evaluation Studies as Topic; Humans; Neoplasms; Prognosis; Sulfonylurea Compounds | 1995 |
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule.
Topics: Administration, Oral; Anemia; Antineoplastic Agents; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Hemolysis; Humans; Male; Methemoglobinemia; Middle Aged; Neoplasms; Sulfonylurea Compounds | 1994 |
Early clinical investigation of sulofenur with a daily schedule in advanced solid tumours.
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Middle Aged; Neoplasms; Sulfonylurea Compounds | 1997 |
Novel chemotherapeutic agents in early clinical development.
Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans; Imides; Irinotecan; Isoquinolines; Naphthalimides; Neoplasms; Organophosphonates; Paclitaxel; Pyrazoles; Quinazolines; Sulfonylurea Compounds; Terpenes; Trimetrexate | 1990 |
4 other study(ies) available for sulofenur and Neoplasms
| Article | Year |
|---|---|
[Antitumor activity of N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)-urea, LY 186641 against various human cancers using subrenal capsule assay].
Topics: Antineoplastic Agents; Colorectal Neoplasms; Esophageal Neoplasms; Humans; Lymphoma; Neoplasms; Subrenal Capsule Assay; Sulfonylurea Compounds | 1990 |
Kinetics of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641) in humans.
Topics: Administration, Oral; Half-Life; Humans; Methemoglobinemia; Neoplasms; Sulfonylurea Compounds; Time Factors | 1990 |
Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).
Topics: Antineoplastic Agents; Drug Evaluation; Female; Humans; Male; Methemoglobinemia; Middle Aged; Neoplasms; Sulfonylurea Compounds; Time Factors | 1989 |
Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.
Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Middle Aged; Neoplasms; Sulfonylurea Compounds; Tumor Stem Cell Assay | 1989 |